C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/11 (2006.01) C07K 14/46 (2006.01) C07K 14/47 (2006.01) C12N 15/63 (2006.01) C12Q 1/68 (2006.01) G01N 33/53 (2006.01) G01N 33/566 (2006.01)
Patent
CA 2507403
This invention relates to a screening method for the identification of agents which modulate the activity of the CIZ1 DNA replication protein as a target for intervention in cancer therapy and includes agents which modulate said activity. The invention also relates to the use of the DNA replication protein, and its RNA transcripts in the prognosis and diagnosis of proliferative disease e.g.,cancer.
L'invention se rapporte à un procédé de criblage permettant d'identifier des agents modulant l'activité d'une protéine de réplication de l'ADN servant de cible pour une intervention dans une thérapie contre le cancer et comportant des agents modulant ladite activité. L'invention se rapporte également à l'utilisation d'une protéine de réplication de l'ADN, et à ses produits de la transcription de l'ARN dans le pronostic et le diagnostic de maladies proliférantes, notamment le cancer.
Cizzle Biotechnology Limited
Ridout & Maybee Llp
Yorkshire Cancer Research
LandOfFree
Ciz1 splice variants does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ciz1 splice variants, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ciz1 splice variants will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1841195